Traws Pharma Defers Planned Phase 2a Influenza Study Of Tivoxavir Marboxil After Negative UK MHRA Review; Cash Runway Extends To Q1 2027; Advancing Alternative Influenza Antiviral Candidates

Benzinga Newsdesk www.benzinga.com Neutral 87.0%

Neg 0% Neu 87% Pos 0%

-SEC Filing

Comments

No comments yet. Be the first!